Edwards Lifesciences Form 144: Broker Cashless Exercise

Accepted by SEC EDGAR 03/11/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Edwards Lifesciences (EW) submitted a Form 144 notice relating to Common Stock with a broker identified as Charles Schwab & Co., Inc. The filing lists a transaction date of 03/11/2026 described as an Employee Stock Option Exercise with “Broker Payment for Cashless Exercise.” The filing also lists two prior entries under "Securities Sold During The Past 3 Months" for Daniel J. Lippis with dated entries 12/12/2025 and 01/09/2026 and amounts 85625.00 and 87332.00 respectively.

Insights

Securities Compliance Analyst

Form 144 filed for an employee option cashless exercise recorded via broker on 03/11/2026.

The notice lists Charles Schwab & Co., Inc. as the broker and describes the method as a Broker Payment for Cashless Exercise. This indicates the exercise used broker-assisted withholding or sale mechanics to satisfy exercise taxes or option costs.

Disclosure includes two prior reported entries for Daniel J. Lippis dated 12/12/2025 and 01/09/2026 with amounts 85625.00 and 87332.00; the excerpt does not state units or cash‑flow recipients beyond the broker identifier.

Corporate Governance Specialist

Filing is routine regulatory notice of a shares disposition tied to option exercise, not a corporate action.

The record names the issuer as Edwards Lifesciences Corporation and the security class as Common. The document frames the event as an employee exercise rather than a company-initiated issuance.

Timing and numeric entries are stated in the excerpt; further transaction-level detail (exact share counts, proceeds, or purchaser identities) are not shown in the provided text.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Edwards Lifesciences' (EW) Form 144 filed 03/11/2026 state?

The Form 144 records a Common Stock transaction processed through Charles Schwab & Co., Inc. on 03/11/2026. It is described as an Employee Stock Option Exercise using a Broker Payment for Cashless Exercise method.

Who is listed as the broker on the EW Form 144?

The filing lists Charles Schwab & Co., Inc. as the broker. The broker is associated with the transaction dated 03/11/2026 and the filing labels the method as broker payment for a cashless exercise.

What prior sales are disclosed for Daniel J. Lippis in the filing?

The excerpt shows two entries for Daniel J. Lippis dated 12/12/2025 and 01/09/2026 with recorded amounts 85625.00 and 87332.00. The filing places these under "Securities Sold During The Past 3 Months."

Does the Form 144 state who receives proceeds from the transaction?

The excerpt does not specify proceeds recipients beyond naming the broker. The filing describes the method as a Broker Payment for Cashless Exercise, but cash‑flow recipients are not detailed in the provided text.

Which issuer and security class are referenced in the Form 144?

The issuer is identified as Edwards Lifesciences Corporation and the security class is listed as Common. The filing associates the security with the NYSE in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002004380
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Lippis Daniel J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3057	261013.00	580800000	03/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Employee Stock Option Exercise - see remarks	EDWARDS LIFESCIENCES CORPORATION			3057	03/11/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	12/12/2025	1019	85625.00
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	01/09/2026	1019	87332.00

144: Remarks and Signature

Remarks	The options on this filing may be sold over various dates.
Date of Notice	03/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel J. Lippis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)